Status:
COMPLETED
Validation of a Software and the Follow-up of Anteropoterior Migration of Stent
Lead Sponsor:
Nurea
Conditions:
Aortic Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
The treatment of aortic aneurysms is today based on different indicators (diameters, lengths, angles, volumes of the arteries) measured on CT scan images. Several indicators are time consuming and com...
Detailed Description
Control and quality assurance will be applied in the investigation site. The monitor mandated by the sponsor Nurea will ensure the follow-up and the proper completion of the study, the collection of d...
Eligibility Criteria
Inclusion
- Male or female ≥18 years of age
- Thoraco-abdominal Aneurysm
- Thoracic aortic aneurysm
- Or Infra-renal abdominal aortic aneurysm
- Or Juxta renal abdominal aortic aneurysm
- With or without calcification
- With or without stent
- For part 2: patient treated by endurant (Medtronic) with sideways displacement during follow-up (more than 5mm)
Exclusion
- Patients with
- Ruptured aneurysms,
- Aortic dissections.
Key Trial Info
Start Date :
June 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 4 2023
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT05287828
Start Date
June 16 2022
End Date
May 4 2023
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Jean Minjoz
Besançon, France, 25000